Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cance... GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its key drug candidates are OXS-2175, targeting the treatment of triple-negative breast cancer; OXS-4235, targets the treatment of multiple myeloma and associated osteolytic lesions; and OXS-1550, targets cancer cells expressing the CD19 receptor and CD22 receptor. Its TriKE and TetraKE platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.08 | 2.7972027972 | 2.86 | 3.2 | 2.612 | 127651 | 3.06750511 | CS |
| 4 | 0.2 | 7.29927007299 | 2.74 | 4.1 | 1.72 | 1246094 | 2.81764224 | CS |
| 12 | 0.93 | 46.2686567164 | 2.01 | 4.1 | 1.72 | 403152 | 2.82143323 | CS |
| 26 | 0.21 | 7.69230769231 | 2.73 | 4.1 | 1.72 | 189579 | 2.8058602 | CS |
| 52 | -4.932 | -62.6524390244 | 7.872 | 10.6599 | 1.72 | 458552 | 6.2193931 | CS |
| 156 | -87.36 | -96.7441860465 | 90.3 | 112.2 | 1.72 | 279829 | 18.91347222 | CS |
| 260 | -162.06 | -98.2181818182 | 165 | 591.993 | 1.72 | 315153 | 100.56209646 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
